Φορτώνει......
The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies
The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases. To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three Bo...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Toxins (Basel) |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5666356/ https://ncbi.nlm.nih.gov/pubmed/28974033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins9100309 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|